Soleno Therapeutics (SLNO) Cost of Revenue: 2014-2017
Historic Cost of Revenue for Soleno Therapeutics (SLNO) over the last 2 years, with Jun 2017 value amounting to $42,000.
- Soleno Therapeutics' Cost of Revenue fell 74.55% to $42,000 in Q2 2017 from the same period last year, while for Jun 2017 it was $690,306, marking a year-over-year decrease of 58.63%. This contributed to the annual value of $26,000 for FY2017, which is 98.28% down from last year.
- According to the latest figures from Q2 2017, Soleno Therapeutics' Cost of Revenue is $42,000, which was up 55.56% from $27,000 recorded in Q1 2017.
- In the past 5 years, Soleno Therapeutics' Cost of Revenue ranged from a high of $538,000 in Q1 2016 and a low of $27,000 during Q1 2017.
- For the 3-year period, Soleno Therapeutics' Cost of Revenue averaged around $312,478, with its median value being $329,500 (2015).
- Per our database at Business Quant, Soleno Therapeutics' Cost of Revenue soared by 455.95% in 2015 and then slumped by 94.98% in 2017.
- Soleno Therapeutics' Cost of Revenue (Quarterly) stood at $156,359 in 2014, then skyrocketed by 218.80% to $498,470 in 2015, then plummeted by 55.40% to $222,306 in 2016, then slumped by 74.55% to $42,000 in 2017.
- Its Cost of Revenue stands at $42,000 for Q2 2017, versus $27,000 for Q1 2017 and $222,306 for Q4 2016.